Compstatin control peptide (TFA)

• UNSPSC Description:

  Compstatin control peptide TFA is a negative control of Compstatin (HY-P1036). Compstatin is a potent complement system C3 inhibitor[1].

• Target Antigen:

  Others

• Type:

  Peptides

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/compstatin-control-peptide-tfa.html

• Solubility:

  H2O

• Smiles:

  OC(C(F)(F)F)=O.CC[C@H](C)[C@H](N)C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(N[C@H](C(N)=O)[C@H](O)C)=O)=O)=O)CC1=CN=CN1)=O)CC2=CN=CN2)=O)=O)CC3=CNC4=CC=CC=C34)=O)=O)=O)=O)=O)=O

• Molecular Weight:

  1488.65 (free base)

• References & Citations:

  [1]Sahu A, et al. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J Immunol. 2000 Sep 1;165(5):2491-9.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported